ArticleBMC biotechnology2025
Green synthesis of silver nanoparticles using cocoon extract of Bombyx mori L.: therapeutic potential in antibacterial, antioxidant, anti-inflammatory, and anti-tumor applications.
Article in BMC biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Green-Synthesized Silver Nanoparticles fromNanomaterials (Basel, Switzerland) · 2026Article
- Antibacterial and cytotoxic activity of biosynthesis gold nanoparticles using Morus nigra leaf extract.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2026Article
- Article
- Green mycosynthesis of a CuO/ZnO heterojunction nanocomposite using Aspergillus terreus and its antibacterial and anti-virulence activity against multidrug-resistant Escherichia coli.Scientific reports · 2026Article
- Green synthesis of silver nanoparticles from Kedrostis nana (Lam.) Cogn. extracts and its biological activities.Frontiers in chemistry · 2026Article
- Biogenic synthesis of silver nanoparticles using Zaleya pentandra and investigation of their biological activities.Scientific reports · 2025Article
- Comprehensive Review of Silver Nanoparticles in Food Packaging Applications.International journal of molecular sciences · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bombyx mori silk is one of the most extensively studied types of silk due to its unique mechanical properties and biocompatibility, which have enabled its Utilization in medical applications Including surgical sutures since the second century. In the present study, a new method for the biosynthesis of silver nanoparticles (AgNPs) was explored by applying Bombyx mori cocoon extract as a sustainable and eco-friendly biological source. Unlike previous studies that primarily utilized plant or microbial extracts, this approach offers a more efficient alternative due to the unique protein and polyphenol content of silk cocoons, which enhances the stability and biological properties of the biosynthesized nanoparticles. The resulting AgNPs exhibited significant antibacterial, antioxidant, anti-inflammatory, and cytotoxic properties, opening new avenues for their therapeutic applications. This study expands the range of biological materials used in AgNP synthesis and provides deeper insight into how different bioactive components influence their functional properties. In this study, AgNPs were biosynthesized by mechanically processing extracted raw silk material with silver nitrate (AgNO₃). The synthesized nanoparticles were characterized by implementing several physicochemical techniques, including UV-visible spectrophotometry, FTIR, and XRD, and their morphology was examined through Transmission Electron Microscopy (TEM). The obtained AgNPs displayed a distinct absorption peak at 420 nm, with a particle size ranging between 5 and 25 nm, and displayed characteristic FTIR and XRD patterns typical of silver nanoparticles. The biosynthesized AgNPs demonstrated significant antimicrobial activity against Staphylococcus aureus (ATCC25923), Staphylococcus haemolyticus (ATCC29968), Escherichia coli (ATCC8739), and Klebsiella pneumoniae (ATCC2146). The antioxidant potential, assessed via the DPPH assay, yielded an IC50 value of 4.94 µg/ml, while the anti-inflammatory effect, evaluated using the membrane stabilization technique, showed an IC50 of 7.14 µg/ml. Additionally, AgNPs exhibited notable cytotoxic properties against Caco-2 and PANC1 cell lines, with IC50 values of 177.24 ± 2.01 µg/ml and 208.15 ± 2.79 µg/ml, respectively. Conversely, their impact on normal HFB-4 cells was minimal, with an IC50 of 582.33 ± 6.37 µg/ml, indicating a favorable safety profile. These observations highlight the multifunctional potential of silk-derived AgNPs, suggesting their applicability in various biomedical fields.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.